2008
DOI: 10.1016/j.jmb.2008.03.048
|View full text |Cite
|
Sign up to set email alerts
|

Phage Display and Crystallographic Analysis Reveals Potential Substrate/Binding Site Interactions in the Protein Secretion Chaperone CsaA from Agrobacterium tumefaciens

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2010
2010
2021
2021

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 52 publications
0
1
0
Order By: Relevance
“…The biological significance of this result is underlined by the fact that a synthetic peptide derived from the identical region of a receptor which does not bind the toxin, and which differs by only a single amino acid, was unable to inhibit toxin binding, suggesting that the selected peptide had identified the toxin binding site. Other examples in which binding epitopes have been identified for different proteins include concanavalin A (Scott et al, 1992), p53 (Stephen and Lane, 1992;Lane and Stephen, 1993;Stephen et al, 1995), HLA (Hammer et al, 1992(Hammer et al, , 1993(Hammer et al, , 1994, amyloid beta (Magdesian et al, 2005), hepatitis B (Deng et al, 2007), CsaA (Feldman et al, 2008), and mdm2 (Bottger et al, 1996).…”
Section: Protein-binding Sitesmentioning
confidence: 99%
“…The biological significance of this result is underlined by the fact that a synthetic peptide derived from the identical region of a receptor which does not bind the toxin, and which differs by only a single amino acid, was unable to inhibit toxin binding, suggesting that the selected peptide had identified the toxin binding site. Other examples in which binding epitopes have been identified for different proteins include concanavalin A (Scott et al, 1992), p53 (Stephen and Lane, 1992;Lane and Stephen, 1993;Stephen et al, 1995), HLA (Hammer et al, 1992(Hammer et al, , 1993(Hammer et al, , 1994, amyloid beta (Magdesian et al, 2005), hepatitis B (Deng et al, 2007), CsaA (Feldman et al, 2008), and mdm2 (Bottger et al, 1996).…”
Section: Protein-binding Sitesmentioning
confidence: 99%